CME INFORMATION

LEARNING OBJECTIVES

At the end of this activity, learners will be able to:

• Understanding the major drivers associated with disparity in hypertension control
• Treatment of resistant hypertension
• Discussion of the role of SGLT2 inhibitors and GLP-1 medications in the treatment of hypertension
• Evaluation and treatment of challenging cases
• Lifestyle approaches in patients with hypertension
• Research updates in Remote Blood Pressure monitoring and Treatment Intensification

ACCREDITATION STATEMENT

The Southern California Permanente Medical Group is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The Southern California Permanente Medical Group designates this Live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CERTIFICATE OF PARTICIPATION

Non-Physician Participants:  Attendees can report up to 6.25 hours of participation towards their accrediting body (licensure). In lieu of the provider number Attendees can write ‘CME’ in the space provided, if applicable.

TARGET AUDIENCE

Primary Target Group: Family Medicine physicians, Internal Medicine physicians (General and all subspecialties) Population Care providers
Secondary Target Group: Physicians in all other specialties (except: anesthesiology, HNS, pathology, pediatrics, plastic surgery, radiology, radiation oncology), Advance Practice Providers and RNs in all specialties above, and PharmDs

Regions: All